Cargando…
Clinical observation of glucocorticoid therapy for critically ill patients with COVID-19 pneumonia
OBJECTIVE: We aimed to investigate the clinical effects of intravenous glucocorticoid (GC) therapy for severe COVID-19 pneumonia. METHODS: Seventy-two patients hospitalized with severe COVID-19 pneumonia who were discharged or died between 5 January 2020 and 3 March 2020 at Huangshi Infectious Disea...
Autores principales: | Zhu, Yingjie, Chen, Dongmei, Zhu, Yanfang, Ge, Xuhua, Li, Zhuo, Miao, Hongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972059/ https://www.ncbi.nlm.nih.gov/pubmed/36843426 http://dx.doi.org/10.1177/03000605221149292 |
Ejemplares similares
-
Secondary bloodstream infection in critically ill patients with COVID-19
por: Zhang, Junli, et al.
Publicado: (2021) -
Clinical features and risk factors of severely and critically ill patients with COVID-19
por: Chu, Xin, et al.
Publicado: (2022) -
Glucocorticoid Receptor Expression in Peripheral WBCs of Critically Ill Children*
por: Shibata, Audrey R. Ogawa, et al.
Publicado: (2015) -
Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19
por: Li, Yan, et al.
Publicado: (2020) -
Risk factors for mortality in postoperative peritonitis in critically ill patients
por: Launey, Yoann, et al.
Publicado: (2017)